Invention Grant
- Patent Title: Inducible caspases and methods for use
-
Application No.: US17830773Application Date: 2022-06-02
-
Publication No.: US11718656B2Publication Date: 2023-08-08
- Inventor: Eric M. Ostertag , Devon Shedlock
- Applicant: Poseida Therapeutics, Inc.
- Applicant Address: US CA San Diego
- Assignee: Poseida Therapeutics, Inc.
- Current Assignee: Poseida Therapeutics, Inc.
- Current Assignee Address: US CA San Diego
- Agency: Cooley LLP
- Agent Matthew Pavao; Ivor Elrifi
- The original application number of the division: US16339710
- Main IPC: C12N15/52
- IPC: C12N15/52 ; C07K14/705 ; C07K14/47 ; A61P37/00 ; A61P31/00 ; A61P3/00 ; A61P17/02 ; A61P29/00 ; A61P35/00 ; A61K35/17 ; C12N5/0783 ; C12N9/50

Abstract:
The disclosure provides inducible caspase polypeptides, compositions comprising inducible caspase polypeptides and sequences encoding the same, cells modified to express the polypeptides and compositions of the disclosure, as well as methods of making and methods of using same for adoptive cell therapy.
Public/Granted literature
- US20230002469A1 INDUCIBLE CASPASES AND METHODS FOR USE Public/Granted day:2023-01-05
Information query
IPC分类: